You have few questions, so I’ll try and cover in point form:
- low revenue generation atm (growing via Europe) - burn rate >$800k pm (give or take) - require additional data to obtain fda etc - need cash to operate/ remain listed and have sufficient run way to negotiate partner/ TO deal - crap market to raise cash atm (particularly pharma space) - CR price need to be attractive enough to achieve say 50% take up from existing holders and shortfall investors (yes they will have been consulted and had the company by the balls) - Now execute partner deal…on what terms who knows
OSL Price at posting:
1.1¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)